Breaking News

Cambrex Expands Biopharmaceutical Testing Services Biz

New capabilities apply to a range of therapeutics, including bacteriophage and mammalian viruses, recombinant proteins, mAbs, and nucleic acids.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cambrex, a global CDMO providing drug substance, drug product, and analytical services, is significantly expanding its existing biopharmaceutical testing services business. The expansion includes 11 additional cGMP labs at Cambrex’s Durham, NC facility and broadens its service offering for large molecule and viral/cell-based therapeutics.     “We are excited to be adding to our fast-growing biopharmaceutical services business,” said Cambrex CEO Thomas Loewald. “Buil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters